Personalis has expanded and extended its partnership with Tempus AI to include colorectal cancer in their NeXT Personal MRD test.
Inconsistent use of CFCs—especially around replacement claims—is causing costly inefficiencies in healthcare billing.
The FDA has approved Thermo Fisher’s Oncomine Dx Express Test on the Genexus Dx Integrated Sequencer as a companion diagnostic for ZEGFROVY.
Bio-Rad Laboratories will showcase its latest clinical diagnostic solutions and host a QC workflow optimization workshop at ADLM 2025.
Researchers propose developing tiny chemical sensors that detect VOCs in bodily fluids to rapidly diagnose bacterial infections.
